Changes in scientific understanding are prompting renewed scrutiny of disease names and their effects on how patients, clinicians, and researchers view conditions.
My child's class has been closed, so I will be taking tomorrow off.There was a day when I received that message from three ...
An eight-year study of 3,496 rare disease hospitalizations at a tertiary hospital in northern Henan reveals rising admission ...
5don MSNOpinion
Rare disease patients denied medical expense assistance because of support obligors' income and assets, urgent system reform needed
“Rare disease patients denied medical expense assistance because of ‘support obligors’ income and assets’” ... Urgent system ...
Morning Overview on MSN
The FDA approved the first treatment for Sanfilippo syndrome type A, a fatal childhood brain disease
Children with Sanfilippo syndrome type A have spent decades with nothing to slow the disease that is taking their abilities ...
Day Care Infection Prevention and Spread Prevention Training Record TemplateThis is a template for recording "Training for the Prevention and Spread of Infectious Diseases" used in day care (day ...
Barclays analyst Christopher Pasquale is watching this opportunity, and he lays out a positive outlook for the sector as a whole. In a note earlier this month, Pasquale lays out a case for buying in, ...
A new case series and literature review suggest the interleukin-4 and interleukin-13 blocker dupilumab may bring relief to ...
Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous ...
Under current law, even non-dermatologists may list dermatology as a treatment department. However, clinics run by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results